XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation
15.
Stock-Based Compensation

2021 Stock Option Plan

In January 2022, the Company's Board of Directors approved the 2021 Stock Option and Incentive Plan (the "2021 Plan"), which supersedes the 2016 Stock Option and Grant Plan and the 2006 Stock Incentive Plan and provides for the grant of incentive stock options, nonqualified stock options, restricted stock awards and restricted stock units to employees, directors, and nonemployees of the Company. The 2021 Plan was authorized initially to issue 9,583,570 shares, plus on January 1, 2023 and each January 1 thereafter, the number of shares of Stock reserved and available for issuance under the Plan shall be cumulatively increased by 4 percent of the number of shares of Stock issued and outstanding on the immediately preceding December 31. Under the 2021 Plan, 7,375,070 shares remained available for issuance at June 30, 2023.

Options and restricted stock awards generally vest based on the grantee’s continued service with the Company during a specified period following a grant as determined by the Board of Directors and expire ten years from the grant date. In general, awards typically vest in three to four years, but vesting conditions can vary based on the discretion of the Company’s Board of Directors.

The fair value of the options is estimated at the grant date using Black-Scholes and recognized over the vesting period, taking into account the terms and conditions upon which options are granted. The fair value of restricted stock awards is the fair value at the date of grant reduced by the exercise price of the award, if any. The fair value of both options and restricted stock awards are amortized on a straight-line basis over the requisite service period of the awards.

Stock-based compensation expense is summarized for employees and nonemployees, by category in the accompanying condensed consolidated statements of operations as follows (in thousands):

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Research and development

 

$

209

 

 

$

3,008

 

 

$

543

 

 

$

8,073

 

Selling, general and administrative

 

 

2,175

 

 

 

4,968

 

 

 

3,932

 

 

 

13,892

 

Total

 

$

2,384

 

 

$

7,976

 

 

$

4,475

 

 

$

21,965

 

 

 

Stock Option Activity

The following table summarizes the Company’s stock option activity during the six months ended June 30, 2023:

 

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price per
Share

 

 

Weighted-
Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding at December 31, 2022

 

 

12,798,479

 

 

$

3.97

 

 

 

5.80

 

 

$

25

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited - unvested

 

 

(158,733

)

 

$

4.02

 

 

 

 

 

 

 

Forfeited - vested

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(999,070

)

 

$

4.12

 

 

 

 

 

 

 

Outstanding at June 30, 2023

 

 

11,640,676

 

 

$

3.95

 

 

 

5.32

 

 

$

 

Exercisable at June 30, 2023

 

 

9,827,923

 

 

$

3.92

 

 

 

4.75

 

 

$

 

Vested and Expected to Vest at June 30, 2023

 

 

11,640,676

 

 

$

3.95

 

 

 

5.32

 

 

$

 

 

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the common stock. The total fair value of options vested during the three and six months ended June 30, 2023 was $1.0 million and $2.9 million, respectively.

At June 30, 2023, there was $4.1 million unrecognized compensation cost related to unvested stock option grants under the 2021 Plan, which was expected to be recognized over a weighted-average period of 2.1 years.

Restricted Stock Unit (“RSU”) Activity

The following table summarizes the Company’s RSU activity during the six months ended June 30, 2023:

 

 

Number of RSUs

 

 

Weighted-
Average Grant Date Fair Value

 

Outstanding and Unvested at December 31, 2022

 

 

4,083,070

 

 

$

4.31

 

Granted

 

 

 

 

 

 

Vested

 

 

(10,088

)

 

$

8.26

 

Forfeited

 

 

(378,182

)

 

$

3.35

 

 Outstanding at June 30, 2023

 

 

3,694,800

 

 

$

4.39

 

Each RSU entitles the holder to one share of common stock on vesting and the RSU awards are based on a cliff vesting schedule over requisite service periods in which the Company recognizes compensation expense for the RSUs. Vesting of the RSUs is subject to the satisfaction of certain service and or certain performance conditions. The Company recognizes the estimated grant date fair value of these awards as stock-based compensation expense over the service and or performance periods based upon its determination of whether it is probable that the service and or performance conditions will be achieved. The Company assesses the probability of achieving the service and our performance conditions at each reporting period. Cumulative adjustments, if any, are recorded to reflect subsequent changes in the estimated or actual outcome of service and or performance-related conditions.

At June 30, 2023, unrecognized compensation cost for RSU awards granted totaled $5.4 million, which was expected to be recognized over a weighted-average period of 2.7 years.